Helixomer
Helixomer is a preclinical company developing a novel RNA aptamer platform. Helixomer's lead drug product is a reversible, intravenous anticoagulant.
Alert Banner
Alert:Watch the Boston Globe Today’s video on why North Carolina is an attractive place to grow a life sciences business, including lower business costs and highly skilled workforce.
Close Search Window
